三星医疗（601567）：配用电全球化布局，持续突破海外市场

Investment Rating - The report initiates coverage with a rating of "Buy" and sets a target price of 32.40 CNY [4][24]. Core Insights - The company has established a global marketing and operational system for its smart power distribution business, focusing on key markets in Europe, the Middle East, and Latin America, while maintaining a leading position in the domestic market [2][12]. - The company is expected to achieve total revenues of 14.80 billion CNY in 2025, with a year-on-year growth rate of 1.4%, and net profit attributable to shareholders of 1.73 billion CNY, reflecting a decrease of 23.3% [23]. Summary by Sections Financial Summary - Total revenue projections for 2025-2027 are 14.80 billion CNY, 16.27 billion CNY, and 18.49 billion CNY, with growth rates of 1.4%, 9.9%, and 13.6% respectively [10][23]. - Net profit attributable to shareholders is forecasted at 1.73 billion CNY, 1.90 billion CNY, and 2.20 billion CNY for the same period, with changes of -23.3%, 9.5%, and 16.1% respectively [10][23]. - Earnings per share (EPS) are expected to be 1.23 CNY, 1.35 CNY, and 1.57 CNY for 2025, 2026, and 2027 [10][23]. Business Operations - The company has a global presence with 8 production bases and over 40 sales centers, covering more than 70 countries and regions [16]. - The overseas distribution business has made significant strides, particularly in Europe, the Middle East, and Latin America, with recent contracts in Hungary, Romania, and Kyrgyzstan [17][18]. - The domestic power distribution business remains strong, focusing on local grid projects and expanding into new customer segments, including renewable energy and data centers [19]. Market Position - The company is recognized as the Chinese firm with the most extensive coverage in Europe, operating in 16 countries [16]. - The overseas revenue for the smart power distribution segment reached 1.495 billion CNY in the first half of 2025, marking a year-on-year increase of 50.89% [19]. - The overall order backlog as of the end of Q3 2025 was 17.914 billion CNY, reflecting a year-on-year growth of 14.69% [19].